A microplanning model to improve door-to-door health service delivery: the case of Seasonal Malaria Chemoprevention in Sub-Saharan African villages.
Burkina Faso
CHW
Community health worker
Door-to-door
Malaria
Microplanning
Model
SMC
Satellite imagery
Seasonal malaria chemoprevention
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
07 Dec 2020
07 Dec 2020
Historique:
received:
26
09
2020
accepted:
25
11
2020
entrez:
8
12
2020
pubmed:
9
12
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Malaria incidence has plateaued in Sub-Saharan Africa despite Seasonal Malaria Chemoprevention's (SMC) introduction. Community health workers (CHW) use a door-to-door delivery strategy to treat children with SMC drugs, but for SMC to be as effective as in clinical trials, coverage must be high over successive seasons. We developed and used a microplanning model that utilizes population raster to estimate population size, generates optimal households visit itinerary, and quantifies SMC coverage based on CHWs' time investment for treatment and walking. CHWs' performance under current SMC deployment mode was assessed using CHWs' tracking data and compared to microplanning in villages with varying demographics and geographies. Estimates showed that microplanning significantly reduces CHWs' walking distance by 25%, increases the number of visited households by 36% (p < 0.001) and increases SMC coverage by 21% from 37.3% under current SMC deployment mode up to 58.3% under microplanning (p < 0.001). Optimal visit itinerary alone increased SMC coverage up to 100% in small villages whereas in larger or hard-to-reach villages, filling the gap additionally needed an optimization of the CHW ratio. We estimate that for a pair of CHWs, the daily optimal number of visited children (assuming 8.5mn spent per child) and walking distance should not exceed 45 (95% CI 27-62) and 5 km (95% CI 3.2-6.2) respectively. Our work contributes to extend SMC coverage by 21-63% and may have broader applicability for other community health programs.
Sections du résumé
BACKGROUND
BACKGROUND
Malaria incidence has plateaued in Sub-Saharan Africa despite Seasonal Malaria Chemoprevention's (SMC) introduction. Community health workers (CHW) use a door-to-door delivery strategy to treat children with SMC drugs, but for SMC to be as effective as in clinical trials, coverage must be high over successive seasons.
METHODS
METHODS
We developed and used a microplanning model that utilizes population raster to estimate population size, generates optimal households visit itinerary, and quantifies SMC coverage based on CHWs' time investment for treatment and walking. CHWs' performance under current SMC deployment mode was assessed using CHWs' tracking data and compared to microplanning in villages with varying demographics and geographies.
RESULTS
RESULTS
Estimates showed that microplanning significantly reduces CHWs' walking distance by 25%, increases the number of visited households by 36% (p < 0.001) and increases SMC coverage by 21% from 37.3% under current SMC deployment mode up to 58.3% under microplanning (p < 0.001). Optimal visit itinerary alone increased SMC coverage up to 100% in small villages whereas in larger or hard-to-reach villages, filling the gap additionally needed an optimization of the CHW ratio.
CONCLUSION
CONCLUSIONS
We estimate that for a pair of CHWs, the daily optimal number of visited children (assuming 8.5mn spent per child) and walking distance should not exceed 45 (95% CI 27-62) and 5 km (95% CI 3.2-6.2) respectively. Our work contributes to extend SMC coverage by 21-63% and may have broader applicability for other community health programs.
Identifiants
pubmed: 33287825
doi: 10.1186/s12913-020-05972-2
pii: 10.1186/s12913-020-05972-2
pmc: PMC7720067
doi:
Substances chimiques
Antimalarials
0
Types de publication
Clinical Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1128Références
Int J Health Plann Manage. 2020 Jul;35(4):939-959
pubmed: 32310321
Int J Health Geogr. 2012 Jun 27;11:24
pubmed: 22737990
Int J Epidemiol. 2012 Oct;41(5):1293-301
pubmed: 23045201
Malar J. 2015 Sep 17;14:345
pubmed: 26376980
Antimicrob Agents Chemother. 2015 Aug;59(8):4387-96
pubmed: 25918149
Int J Gen Med. 2019 Nov 06;12:395-403
pubmed: 31819592
J Infect Dis. 2014 Nov 1;210 Suppl 1:S102-10
pubmed: 25316823
Acta Trop. 2008 Jan;105(1):28-34
pubmed: 17964522
Geospat Health. 2011 Nov;6(1):21-31
pubmed: 22109860
Nat Commun. 2012 Jun 06;3:881
pubmed: 22673908
J Infect Dis. 2016 Jan 1;213(1):90-9
pubmed: 26142435
Int J Health Geogr. 2009 Jan 22;8:4
pubmed: 19161606
PLoS One. 2018 Mar 5;13(3):e0193296
pubmed: 29505578
Int J Health Geogr. 2013 Jan 23;12:4
pubmed: 23343099
Sci Rep. 2018 Apr 3;8(1):5489
pubmed: 29615763
J Infect Dis. 2014 Nov 1;210 Suppl 1:S118-24
pubmed: 25316825
PLoS One. 2017 Nov 29;12(11):e0187460
pubmed: 29186137
BMJ Glob Health. 2019 Jul 1;4(Suppl 5):e001606
pubmed: 31321093
Malar J. 2017 Aug 10;16(1):325
pubmed: 28797263
Nature. 2020 Aug 28;:
pubmed: 32860027
Int J Health Geogr. 2017 Jan 13;16(1):1
pubmed: 28086893
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003756
pubmed: 22336792
PLoS One. 2011 Feb 14;6(2):e16976
pubmed: 21340029
J Infect Dis. 2016 May 1;213 Suppl 3:S73-8
pubmed: 26908755
PLoS Med. 2011 Feb 01;8(2):e1000409
pubmed: 21304921
PLoS One. 2009 Sep 30;4(9):e7256
pubmed: 19789648